Pretomanid (1) – Dovprela®
Tuberculosis
Characteristics
| Start date | 01.06.2026 |
|---|---|
| Resolution | 19.11.2026 – active procedure |
| INN | Pretomanid |
| Brand name | Dovprela® |
| Pharm. company | Viatris Germany GmbH |
| G-BA Procedure ID | D-1318 |
| Therapeutic area | Infectious diseases Orphan |
| Reason for procedure | Initial assessment |
Associated procedures
<< List of all resolutions